C4 Therapeutics (CCCC) Accumulated Depreciation & Amortization (2019 - 2025)
Historic Accumulated Depreciation & Amortization for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $1.5 million.
- C4 Therapeutics' Accumulated Depreciation & Amortization rose 1442.45% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 1442.45%. This contributed to the annual value of $9.2 million for FY2024, which is 1897.46% up from last year.
- C4 Therapeutics' Accumulated Depreciation & Amortization amounted to $1.5 million in Q3 2025, which was up 1442.45% from $1.1 million recorded in Q2 2025.
- Over the past 5 years, C4 Therapeutics' Accumulated Depreciation & Amortization peaked at $9.2 million during Q4 2024, and registered a low of $448000.0 during Q1 2024.
- Its 5-year average for Accumulated Depreciation & Amortization is $4.8 million, with a median of $6.5 million in 2021.
- Per our database at Business Quant, C4 Therapeutics' Accumulated Depreciation & Amortization surged by 3063.77% in 2021 and then plummeted by 9477.92% in 2024.
- Quarter analysis of 5 years shows C4 Therapeutics' Accumulated Depreciation & Amortization stood at $6.9 million in 2021, then rose by 17.45% to $8.1 million in 2022, then decreased by 4.43% to $7.8 million in 2023, then rose by 18.97% to $9.2 million in 2024, then crashed by 83.42% to $1.5 million in 2025.
- Its last three reported values are $1.5 million in Q3 2025, $1.1 million for Q2 2025, and $456000.0 during Q1 2025.